The Pharmacy Times® Retail Clinical Role section is a comprehensive resource for clinical news and expert insights on issues pertaining to retail, community, and independent pharmacists.
April 29th 2025
A 15-mg dose with a corticosteroid taper regimen was superior to placebo in sustained remission from week 12 to 52.
Vaccine Hesitancy Largely Driven by Negative Views of Vaccines, Pharmaceutical Industry
August 9th 2021The investigators said that attention-grabbing anti-vaccine arguments, regardless of scientific basis, as well as an overall distrust of the pharmaceutical industry, science, and health providers, seems to be primarily responsible.
Read More
Health Outcomes for Patients With Diabetes, Depression May Be Improved By Antidepressants
August 6th 2021Antidepressants may lower the risk of death and serious complications from diabetes for patients with both diabetes and depression, according to a study published in the Journal of Clinical Endocrinology & Metabolism.
Read More
Positive Top-Line Results Announced from Clinical Trial of Ritlecitinib in Alopecia Areata
August 4th 2021In the study, ritlecitinib 50 mg and 30 mg achieved the primary efficacy endpoint, specifically the proportion of patients with less than or equal to 20% scalp hair loss after 6 months of treatment versus placebo.
Read More
Though the benefits of continuous glucose monitoring for patients with diabetes has been previously demonstrated, the investigators said that these benefits have only been well-established for patients with type 1 diabetes or patients with type 2 diabetes treated with multiple daily insulin injections.
Read More